• Publications
    Expected Returns Articles
  • Research
    Companies Funds Top 40 My Studies
  • Stock Screen
    New Stock Screen Manage Screens
  • Dashboards
    My Dashboards New Dashboard
  • Forum
  • Events
  • Search
  • Contact Us
  • Sign In

Jazz Pharmaceuticals (JAZZ)

Company Ticker Sector | Industry Quality PAR
Jazz Pharmaceuticals JAZZ Healthcare | Biotechnology 64 15.3%
Current Price (08/12) $157.08
CAPS Rating (Rate this stock on CAPS)
Expected Income Statement
Current Sales 3,300.4
Sales Growth Forecast 12.4%
Net Profit Margin 30.2%
Projected Shares Outstanding 69.92
EPS - Five year Forecast $25.60
Average P/E Ratio 12.5
Projected Average Price $320.06
Price Appreciation (Annualized) 15.3%
Annual Dividend Yield 0.0%
Projected Annual Return 15.3%
Quality
Financial Strength 69 17.3
EPS Stability 60 15.0
Industry Sales Growth Rate 15.0% 10.4
Industry Net Profit Margin 30.0% 12.6
Calculated Quality Rating 55.2
Fool CAPS

Total Players

287 Outperforms
66 Underperforms
 

All-Stars (64)

50 Outperforms (78%)
14 Underperforms
 
Fundamental Data Updated: 06/03/2022
MIPAR 10.2%  
Sweet Spot 15.2% - 20.2%  
Top In Biotechnology
Ticker Quality PAR
UTHR 88 12.4%
MRNA 77 26.6%
JAZZ 64 15.3%
NVO 86 8.7%
INVA 37 20.4%
Top In Healthcare
Ticker Quality PAR
ICLR 88 18.6%
ALGN 96 16.4%
PCRX 78 20.2%
ICUI 78 19.2%
USPH 94 14.8%

© 2006 - 2022 Manifest Investing. All rights reserved.
About | Terms of Service | Disclaimer | Privacy Policy

Legend
Quality Legend:
Blue Excellent with quality greater than 80.
Green Good with quality between 60 and 80.
Neutral Average or below average with quality between 20 and 60.
Red Poor with quality less than 20.
Companies with less than 10 years of history are penalized by 5 points per year.
PAR Legend:
Green PAR is within the target range of MIPAR +5-10%, currently 5.1%-10.1%
Yellow PAR is above the target range of MIPAR +10%, currently 10.1%
PAR Projected Annual Return
MIPAR The Manifest Investing Median PAR of all stocks in the database.
Company Name Legend:
* Not covered by Value Line Standard Edition.
b Uses price-to-book value for valuation purposes.
P/CF Uses price-to-cash flow for valuation.